Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Commentary · 30 Jan 2023 Case report · 28 Jan 2023 Prostate Cancer Under 40: A Case Report
Prostate Cancer (PCa) is a disease that primarily affects men older than 65 years of age. Early-onset PCa has been defined as PCa diagnosed ≤ 55 years. There is scarce ... information on patients with prostate…
Commentary · 16 Jan 2023 Epidemiologic Screening for Prostate Cancer
Mini review · 30 Dec 2022 Prostate Cancer and the Microbiome: A New Target for Prevention and Treatment
microbiome's influence on human health and illness has come to light. Prostate cancer, which is still the second most common male malignancy globally, may be affected significantly by changes ... microbiota makeup…
Review article · 30 Dec 2022 Hormone Therapy and Prostate Cancer: Reminder and Latest News
treatment in the management of patient with locally advanced and metastatic prostate cancer. A better comprehension of the castration resistance's mechanisms allowed the development of second-generation hormonal…
Mini review · 30 Dec 2022 DNA Hypomethylation in Prostate Cancer is Consistent
With approximately 1.4 million men diagnosed with prostate cancer each year around the world, PCa remains a terrifying threat to life and a source of devastating morbidity. Increased prostate-specific
Short communication · 26 Dec 2022 Analysis radiotherapy for prostate cancer and toxicities of bladder cancer
including a central boost to ordinary fractionated EBRT within the treatment of localized prostate cancer, the five-year biochemical disease-free survival expanded, without altogether expanding poisonous quality. The…
Review article · 25 Dec 2022 Standard of Care for Metastatic Prostate Cancer
Patients with metastatic disease commonly get foundational treatment, with nearby treatment held
Conference abstract · 13 Dec 2022 Types of hormone therapy for prostate cancer
There are two main types of hormone therapy for prostate cancer: The body stops producing hormones and no longer allows them to be produced. The body prevents the binding ... after diagnosis, and some believe it is…
Conference abstract · 13 Dec 2022 Opportunities for early detection of prostate cancer in young men
Introduction: Prostate Cancer (PCa) is a public health problem; it ranks second in incidence in 105 countries and fifth among causes of death in 46 countries. PCa is sometimes verified
Conference abstract · 13 Dec 2022 Atypical presentation of prostatic cancer with left axillary and supraclavicular lymphadenopathy
Introduction: The burden of prostatic cancer is rising in Sudan. Usually, they present late in their disease with urinary tract obstruction, hematuria, bony pain, or cachexia because there ... screening program. Here we…
Conference abstract · 13 Dec 2022 Local availability influences choice of radical treatment for prostate cancer
Introduction: Radical prostatectomy and radiotherapy are both viable options for the treatment of localised prostate cancer. Over the years, medicine has evolved towards a patient-centred approach. Patient…
Conference abstract · 13 Dec 2022 Concordance between biparametric MRI and Radical prostatectomy specimen in the detection of clinically significant prostate cancer and staging
Introduction and Objectives: MRI has an increasing role in the diagnosis and staging of prostate cancer. Multiparametric MRI includes multiple sequences including T2 weighting, diffusion weighting and Dynamic Contrast…
Conference abstract · 13 Dec 2022 Circadian rhythm-related miR-6883-5p suppresses Enzalutamide-resistant prostate cancer proliferation via inhibiting AR-V7 expression
Prostate cancer is the second most prevalent cancer in men and the sixth leading cause of cancer death worldwide. Age, family history, race, tobacco use, obesity, diet, and circadian disruption ... risk factors for…
Conference abstract · 13 Dec 2022 Focal therapy for localized low and intermediate risk Prostate cancer
During the last three decades, prostate cancer detection has decreased regarding the age of men by approximately 10 years. On the other hand, men’s life expectancy has increased ... years. Along with the high rates of…
Short communication · 6 Dec 2022 Prostate Cancer Recognition: Using the Random Forest Technique and Other Ml Techniques
exact etiology of prostate cancer is unknown. Prostate cells alter their DNA, which is how doctors know prostate cancer starts. The instructions that inform a cell what ... multiply and develop faster than usual. In the…
Mini review · 28 Nov 2022 Transplanting a Kidney and having Low-Risk Prostate Cancer in Men
kidney transplant recipients and matched control men without kidney transplants showed similar rates of prostate cancer diagnosis, clinical prostate cancer features, and prostate cancer-specific death. In comparison to…
Research article · 28 Nov 2022 Outcomes, toxicities and dosimetric comparison of different hypofractionated Intensity modulated Radiotherapy techniques for treatment of Localized Prostate Cancer
Background: conventional fractionation IMRT is the standard treatment for localized prostate cancer patients. The objectives of this study were to evaluate safety and efficacy of Hypofractionated radiotherapy with…
Commentary · 22 Nov 2022 Exposure to Metals in the Environment, Blood Oxidative Stress Markers and Prostate Cancer
Commentary · 18 Nov 2022 Management of Patients with Metastatic Prostate Cancer
Opinion · 18 Nov 2022 Clinical Significance of MRI in Prostate Cancer Diagnosis
Case report · 11 Nov 2022 Enzalutamide for Primary Immune Prostate Cancer in Routine Clinical Practice: Results from a Rare Metastasis Study in Japan
Introduction: The effectiveness and safety of romiplostim were evaluated by immune thrombocytopenia
Research article · 31 Oct 2022 Correlation of Serum Prostate Specific Antigen (PSA) with Incidentally Detected Prostatic Cancer in Patients Undergoing TURP for Clinically Benign Prostatomegaly: A Single Centre Study
Objective: The aim of this study is to estimate the incidence of prostatic cancer in patients undergoing transurethral resection of prostate for clinically benign prostatomegaly and its correlation with serum ... Range…
Research article · 13 Oct 2022 Role of Serum Prostatic Acid Phosphatase on Prostate Cancer Patients
well known that serum prostatic acid phosphatase (SPAP) may have a great role on Prostate Cancer Patients (PCPs), but its effects are not clearly identified in the prostate cancer literature

